Literature DB >> 19751149

Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study.

Núria Fernàndez-Sabé1, Carlos Cervera, Francisco López-Medrano, Miguel Llano, Elena Sáez, Oscar Len, Jesús Fortún, Marino Blanes, Rosa Laporta, Julián Torre-Cisneros, Joan Gavaldà, Patricia Muñoz, M Carmen Fariñas, José María Aguado, Asunción Moreno, Jordi Carratalà.   

Abstract

BACKGROUND: Solid-organ transplant (SOT) recipients are classically considered to be at increased risk for listeriosis. However, risk factors for this infection have not been assessed.
METHODS: We carried out a multicenter, matched case-control study (1:2 ratio) from January 1995 through December 2007. Control subjects were matched for center, transplant type, and timing. Conditional logistic regression was performed to identify independent risk factors. Clinical features and outcomes for all case patients were reviewed.
RESULTS: Thirty patients (0.12%) with cases of listeriosis were identified among 25,997 SOT recipients at 15 Spanish transplant centers. In a comparison of case patients with 60 matched control subjects, the following independent risk factors for listeriosis were identified: diabetes mellitus (odds ratio [OR], 5.6; 95% confidence interval [CI], 1.6-19.6; ), P = .007 history of cytomegalovirus infection or disease within the preceding 6 months (OR, 35.9; 95% CI, 2.1-620; P = .014), receipt of high-dose prednisone within the preceding 6 months (OR, 6.2; 95% CI, 1.8-21.1; P = .003), and trimethoprim-sulfamethoxazole (TMP-SMZ) prophylaxis (OR, 0.07; 95% CI, 0.006-0.76; P = .029). Twenty-six patients (86.7%) had bacteremia, and 7 had shock at presentation. Other manifestations included meningoencephalitis (10 cases), spontaneous peritonitis (2), pleural empyema (1), brain abscesses (1), and liver abscesses (1). The 30-day mortality rate was 26.7% (8 of 30 patients died).
CONCLUSIONS: Listeriosis in SOT recipients is uncommon but causes high mortality. Diabetes mellitus, cytomegalovirus infection or disease, and receipt of high-dose steroids are independent risk factors for this infection, whereas TMP-SMZ prophylaxis is a protective factor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751149     DOI: 10.1086/605637

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Listeriosis in patients receiving biologic therapies.

Authors:  M Bodro; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-09       Impact factor: 3.267

Review 2.  The occurrence and prevention of foodborne disease in vulnerable people.

Authors:  Barbara M Lund; Sarah J O'Brien
Journal:  Foodborne Pathog Dis       Date:  2011-05-11       Impact factor: 3.171

Review 3.  Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients.

Authors:  Adem Ilkay Diken; Ozlem Erçen Diken; Onur Hanedan; Seyhan Yılmaz; Ata Niyazi Ecevit; Emir Erol; Adnan Yalçınkaya
Journal:  World J Transplant       Date:  2016-03-24

4.  Listeria monocytogenes meningoencephalitis in adults: analysis of factors related to unfavourable outcome.

Authors:  I Pelegrín; M Moragas; C Suárez; A Ribera; R Verdaguer; S Martínez-Yelamos; F Rubio-Borrego; J Ariza; P F Viladrich; C Cabellos
Journal:  Infection       Date:  2014-06-06       Impact factor: 3.553

5.  Nitric oxide increases susceptibility of Toll-like receptor-activated macrophages to spreading Listeria monocytogenes.

Authors:  Caroline Cole; Stacey Thomas; Holly Filak; Peter M Henson; Laurel L Lenz
Journal:  Immunity       Date:  2012-04-26       Impact factor: 31.745

6.  [Rare superinfection in a COVID-19 patient-A chronology].

Authors:  E Gamon; D Tammena; M Wattenberg; T Augenstein
Journal:  Anaesthesist       Date:  2021-08-24       Impact factor: 1.041

7.  Vascular Endograft Infection with Listeria monocytogenes reated with Surgical Debridement but without Graft Removal.

Authors:  Beate Tanner-Steinmann; Katia Boggian
Journal:  Case Rep Med       Date:  2011-06-27

8.  Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study.

Authors:  Laurence Fardet; Irene Petersen; Irwin Nazareth
Journal:  PLoS Med       Date:  2016-05-24       Impact factor: 11.069

9.  Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities.

Authors:  Ricardo Calderón-Gonzalez; Héctor Terán-Navarro; Elisabet Frande-Cabanes; Eva Ferrández-Fernández; Javier Freire; Soledad Penadés; Marco Marradi; Isabel García; Javier Gomez-Román; Sonsoles Yañez-Díaz; Carmen Álvarez-Domínguez
Journal:  Nanomaterials (Basel)       Date:  2016-08-19       Impact factor: 5.076

10.  Biomarker Tools to Design Clinical Vaccines Determined from a Study of Annual Listeriosis Incidence in Northern Spain.

Authors:  Ricardo Calderon-Gonzalez; Hector Teran-Navarro; José María Marimon; Claudia González-Rico; Jorge Calvo-Montes; Elisabet Frande-Cabanes; Miriam Alkorta-Gurrutxaga; M C Fariñas; Luis Martínez-Martínez; Emilio Perez-Trallero; Carmen Alvarez-Dominguez
Journal:  Front Immunol       Date:  2016-11-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.